Results for:(76 found)
Apr 11, 2013 9:23AM on Top StocksBy Benzinga

Amgen, Celgene and Pharmacyclics see short interest drop recently.

Apr 5, 2013 10:43AM on Top StocksBy MSN Money Partner

McDonalds initiated with an 'overweight,' and Facebook upgraded to 'buy.'

Mar 28, 2013 10:50AM on Top StocksBy Benzinga

There's mixed interest in biotech, biopharmaceutical and emerging pharma companies.

Mar 27, 2013 10:36AM on Top StocksBy TheStockAdvisors

This leading company is conducting 25 late-stage clinical trials for new drugs.

Tags: CELG
Mar 25, 2013 10:46AM on Top StocksBy Benzinga

Health care is in the index's top spot for first time since 1988 and looks to remain strong.

Mar 11, 2013 9:27AM on Top StocksBy Benzinga

Look to these investments this week for strength as stocks continue to outperform.

Feb 13, 2013 4:46AM on Top StocksBy Gene Marcial

This biotech behemoth's appeal is its combined value-and-growth stock characteristics.

Feb 11, 2013 10:01AM on Top StocksBy Minyanville.com

Pomalyst for multiple myeloma is a potentially big and important new treatment for the company.

Tags: CELG

VIDEO ON MSN MONEY

DATA PROVIDERS

Copyright © 2014 Microsoft. All rights reserved.

Fundamental company data and historical chart data provided by Morningstar Inc. Real-time index quotes and delayed quotes supplied by Morningstar Inc. Quotes delayed by up to 15 minutes, except where indicated otherwise. Fund summary, fund performance and dividend data provided by Morningstar Inc. Analyst recommendations provided by Zacks Investment Research. StockScouter data provided by Verus Analytics. IPO data provided by Hoover's Inc. Index membership data provided by Morningstar Inc.

MARKET DISPATCHES

No more Dispatches; here's where to find market news

The Market Dispatches column has been discontinued. Here's where to find the latest stock and business news on MSN Money, and the latest from market writer Charley Blaine.

More